Product
TS-172
Aliases
TS-172 10mg bid, TS-172 20mg tid, TS-172 30mg bid, TS-172 60mg bid
2 clinical trials
2 indications
Indication
HyperphosphatemiaIndication
Adult HealthClinical trial
A Phase 2, Randomized, Placebo-controlled, Double-blind, Dose-finding Study of TS-172 in Hyperphosphatemia Patients on HemodialysisStatus: Completed, Estimated PCD: 2023-12-26
Clinical trial
A Phase 1, Single-Center, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending and Multiple Dose of TS-172 in Healthy Adult SubjectsStatus: Completed, Estimated PCD: 2022-01-26